Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Annals of Surgery|August 11, 2020
Outcomes in Kidney Transplantation Between Veterans Affairs and Civilian Hospitals: Considerations in the Context of the MISSION ActSamuel J Kesseli, Mariya L Samoylova, Dimitrios Moris, et al.
Xenotransplantation|June 21, 2019
The role of human CD46 in early xenoislet engraftment in a dual transplant modelKannan P Samy, Qimeng Gao, Robert Patrick Davis, et al.
Pediatric Transplantation|November 7, 2024
Natural Killer Cell Phenotypes and Clinical Outcomes in Pediatric Kidney TransplantationRiley H Kahan, Nader Abraham, Hui-Jie Lee, et al.
Critical Care Medicine|July 14, 2021
Viral Micro-RNAs Are Detected in the Early Systemic Response to Injury and Are Associated With Outcomes in Polytrauma PatientsDiego Vicente, Seth A Schobel, Simone Anfossi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 18, 2021
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and OutcomesMariya L Samoylova, Kara Wegermann, Brian I Shaw, et al.
World Journal of Surgery|June 4, 2020
Textbook Outcomes in Liver TransplantationDimitrios Moris, Brian I Shaw, Jared Gloria, et al.
International Immunology|October 7, 2004
The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challengeJanine L Ferrant, Christopher D Benjamin, Anne H Cutler, et al.
The Journal of Trauma and Acute Care Surgery|July 7, 2022
Cellular microRNAs correlate with clinical parameters in multiple injury patientsDiego A Vicente, Seth A Schobel, Simone Anfossi, et al.
Transplantation Direct|August 11, 2025
Process Variation in Liver, Kidney, and Pancreas Transplantation: A Multicenter Evaluation From the Consortium for the Holistic Assessment of Risk in TransplantAlexandra T Strauss, Juan Carlos Caicedo, Whitney Welsh, et al.
Plos One|April 8, 2016
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant OutcomesCasey R Dorr, Barry I Freedman, Pamela J Hicks, et al.
Pageof 22